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Effect of growth rate on transcriptomic
responses to immune stimulation in wild-
type, domesticated, and GH-transgenic
coho salmon
Jin-Hyoung Kim1,4, Daniel J. Macqueen2, James R. Winton3, John D. Hansen3, Hyun Park5 and Robert H. Devlin1*
Abstract
Background: Transcriptomic responses to immune stimulation were investigated in coho salmon (Oncorhynchus
kisutch) with distinct growth phenotypes. Wild-type fish were contrasted to strains with accelerated growth arising
either from selective breeding (i.e. domestication) or genetic modification. Such distinct routes to accelerated
growth may have unique implications for relationships and/or trade-offs between growth and immune function.
Results: RNA-Seq was performed on liver and head kidney in four ‘growth response groups’ injected with
polyinosinic-polycytidylic acid (Poly I:C; viral mimic), peptidoglycan (PGN; bacterial mimic) or PBS (control). These
groups were: 1) ‘W’: wild-type, 2) ‘TF’: growth hormone (GH) transgenic salmon with ~ 3-fold higher growth-rate
than W, 3) ‘TR’: GH transgenic fish ration restricted to possess a growth-rate equal to W, and 4) ‘D’: domesticated
non-transgenic fish showing growth-rate intermediate to W and TF. D and TF showed a higher similarity in
transcriptomic response compared to W and TR. Several immune genes showed constitutive expression differences
among growth response groups, including perforin 1 and C-C motif chemokine 19-like. Among the affected
immune pathways, most were up-regulated by Poly I:C and PGN. In response to PGN, the c-type lectin receptor
signalling pathway responded uniquely in TF and TR. In response to stimulation with both immune mimics, TR
responded more strongly than other groups. Further, group-specific pathway responses to PGN stimulation
included NOD-like receptor signalling in W and platelet activation in TR. TF consistently showed the most
attenuated immune response relative to W, and more DEGs were apparent in TR than TF and D relative to W,
suggesting that a non-satiating ration coupled with elevated circulating GH levels may cause TR to possess
enhanced immune capabilities. Alternatively, TF and D salmon are prevented from acquiring the same level of
immune response as TR due to direction of energy to high overall somatic growth. Further study of the effects of
ration restriction in growth-modified fishes is warranted.
Conclusions: These findings improve our understanding of the pleiotropic effects of growth modification on the
immunological responses of fish, revealing unique immune pathway responses depending on the mechanism of
growth acceleration and nutritional availability.
Keywords: Growth, Immunity, Transgenesis, Selective breeding, Pleiotropy, Growth hormone, Coho salmon,
Transcriptomics, Poly I:C, PGN
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Background
Fish health is a critical factor determining the success of
aquaculture [1] and survival of wild fish. In culture, fish
health depends on external variables that can be largely
controlled, for example, water and feed quality, hus-
bandry stress and pathogen exposure. However, intrinsic
factors, underpinned by genetics, are also central to fish
health, including the status of systems controlling
growth, nutrition and immunity, which are major targets
for selective breeding to enhance growth rate and
disease resistance [2–4]. Selective breeding has been
exploited extensively in salmonid aquaculture and re-
sulted in significant gains in target traits [5–9]. While
such changes are of great benefit within the aquaculture
sector, there exist ongoing concerns about the potential
for escaped selectively-bred and domesticated fish to
breed with wild populations and reduce their fitness by
disrupting naturally-adapted genomes through introgres-
sion and hybridization. The genetic and physiological
mechanisms causing phenotypic and fitness changes in
different salmonid genotypes is understood at a basic
level [8, 10, 11], but remains of great interest in the con-
text of selective breeding and for understanding eco-
logical impacts resulting from the interaction of wild
and farmed fish.
Genetic engineering approaches, including transgen-
esis, provide an alternative to selective breeding for
modification of traits of value within aquaculture. Select-
ive breeding classically targets phenotypic variation
without knowledge of the specific underlying genetic
variation but rather alters the frequency of many alleles,
including variants unrelated to the trait of interest. In
contrast, transgenesis typically alters the expression of a
single target gene of known major effect. In salmonids
and other farmed fish species, emphasis has been placed
on the achievement of high growth rates through the
transgenic overexpression of growth hormone (GH) [8,
12–14]. GH transgenic fish possess modified gene ex-
pression, physiology and behaviour, including elevated
appetite, enhanced feeding motivation, elevated feed
conversion efficiency, elevated metabolic rate, and, in
some cases, altered susceptibility to pathogens [14–19].
Despite a considerable body of literature comparing the
characteristics of GH transgenic versus wild-type and
growth-enhanced domesticated phenotypes, to date, the
contrasting effect of GH and selection for high growth
on the immune system remains poorly characterized. In
coho salmon, past work showed that GH transgenesis al-
ters immune phenotypic characteristics, with negative
associated impacts on disease resistance [19, 20]. More-
over, a recent study highlighted a substantial attenuation
of host defence gene responses to immune stimulation
in skeletal muscle of GH transgenic salmon, altering
downstream regulation of master growth controlling
pathways dependent on GH and its impact on growth
rate [21]. However, there are no published studies of the
impact of immune stimulation on key tissues for host
defence in growth-accelerated transgenic fish strains.
The objective of the present study was to improve our
understanding of immune system function in wild-type
versus growth-accelerated salmon strains achieved by
GH transgenesis or selective breeding following domesti-
cation. This was achieved using RNA-Seq to characterize
the transcriptomic responses of liver and head kidney,
each a key immune tissues, to mimics of viral and bac-
terial infection under common garden conditions. The
study revealed complex responses to immune stimula-
tion that also differed among salmon strains with differ-
ent growth rates and between tissue types. The data
reported have importance for future considerations sur-
rounding the applications of transgenesis in aquaculture,
the evaluation of domesticated strains, and for risk as-
sessments on the potential consequences of transgenic
fish entering natural environments.
Results
Comparison of the growth response group
transcriptomes
The overall relative transcriptomic responses (compared
to W fish) of the three growth groups (GH transgenic,
TF; GH transgenic fed W satiating ration, TR; Domesti-
cated, D) to immune stimulation are summarized by
principal component analyses (PCA) (Fig. 1). Separate
PCA plots were generated for the first two principle
components for head kidney and liver treated with the
immune stimulants (Poly I:C or PGN). For head kidney
treated with PBS or Poly I:C, TF and D were clustered
closely compared to TR (Fig. 1a), whereas in treatments
with peptidoglycan (PGN), the three response groups
were more distantly related. In liver, TF and D were
clustered in PBS-treated groups, whereas both Poly I:C
and PGN treated groups both showed more divergence
(Fig. 1b).
Overview of differentially expressed genes
We used two RNA-Seq normalization methods to
establish significantly differentially expressed genes
(DEGs) in this study, DESeq2 and Baggerley’s test (see
Methods). To establish constitutive differences among
the growth response groups in relation to the wild-type,
we performed pairwise comparisons of control (i.e. PBS-
injected) samples for i) D vs. W, ii) TF vs. W and iii) TR
vs. W (Fig. 2b), revealing 129 DEGs for head kidney and
liver, with 18 commonly identified by both normalization
methods (Fig. 2b, Table 1). We also considered the effects
of immune stimulation separately for each growth re-
sponse group and tissue by comparing i) PGN vs. control
and ii) Poly I:C vs. control for W, D, TF, and TR in liver
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and head kidney. A total of 3688 immune-responsive
DEGs were detected, with 357 common to both ap-
proaches (Fig. 2c and d, Additional file 1: Table S1) that
were used for further analysis. These results are expanded
below.
Constitutive differences in expression among growth-
response groups
Constitutive DEGs among control samples for TF, TR,
and D relative to W were determined for head kidney
and liver (Fig. 3; gene lists and fold change values shown
in Table 1). In a cluster analysis of head kidney DEGs,
TF and D clustered together to the exclusion of TR
(Fig. 3a). There were 13 DEGs comparing W with the
PBS-treated control groups for this tissue (Fig. 3a) with
11 annotated in the published coho salmon transcrip-
tome [22]. Methyltransferase DDB-like was highly up-
regulated in all three groups relative to W (Fig. 3a;
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Fig. 1 Principal component analysis (PCA) of all reads from RNA-Seq
analysis for a) Head kidney and b) Liver treated with PBS, PGN and
Poly I:C for. PBS, phosphate-buffered saline; PGN, peptidoglycan; Poly
I:C, polyinosinic-polycytidylic acid. W, non-transgenic (wild-type)
coho salmon on a full satiation ration; TF, GH transgenic coho
salmon on a full satiation ration; TR, GH transgenic coho salmon on
restricted ration equal to that consumed by W; D, domesticated
coho salmon on a full satiation ration
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Fig. 2 Bioinformatic analysis plan for the study. a) Pairwise
assessment within each group, comparing immune-stimulated fish
to their respective group treated with PBS, peptidoglycan (PGN) and
Poly I:C. b) number of differentially expressed genes (DEGs)
identified in the study by two different statistical normalized
methods (Baggerley’s and DESeq2) treated with PBS, c0
peptidoglycan (PGN), and d) Poly I:C. Numbers refer to DEGs
displaying a fold-change ≥3 among fish groups, with a normalized
false discovery rate (FDR) P-value correction < 0.01). See Fig. 1
legend for abbreviations
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Table 1). The sodium channel protein type 4 subunit
alpha B gene was very highly upregulated in both T
groups (53.9/11.9-fold in TF/TR vs. W), whereas D
showed reduced expression vs. W (Fig. 3a; Table 1). In
TR, the genes encoding Leucine-rich repeat-containing
protein 19, one ATP-dependent RNA helicase DHX30-
like, and ORF2 protein were upregulated vs. W, while
the gene encoding B chain crystal structure of avidin
was more highly expressed (4.1 fold) in TF compared to
W (Fig. 3a; Table 1). The gene encoding complement
C1q-like protein 4 precursor had significantly lower ex-
pression in TR than W (Fig. 3a; Table 1). The genes en-
coding Aquaporin 1, Perforin-1-like and Uromodulin,
and two additional uncharacterized protein products
were significantly less transcriptionally abundant in D
compared to W (Fig. 3a and Table 1).
As seen in head kidney, TF and D clustered together
with respect to shared DEGs vs. W in liver (Fig. 3b).
Moreover, 6 DEGs were identified with constitutive
expression differences compared to W; 5 DEGs for TR,
2 DEGs for TF, and none for D (Fig. 3b). The sodium
channel protein type 4 subunit alpha B gene, as in head
kidney, showed highly upregulated expression in both
TF (8.9-fold) and TR (30.2-fold) compared to W
(Table 1). The genes encoding Saxitoxin and
tetrodotoxin-binding protein, Microfibril-associated
glycoprotein 4-like, C-C motif channel protein type 4
subunit alpha B, and Transmembrane protein 116, all
had significantly lower reduced expression in TR vs. W,
whereas fatty acid-binding protein 1 gene had lower ex-
pression in TF specifically (Fig. 3b).
Growth response group responses to immune stimulation
The number of DEGs arising from immunological
stimulation (i.e. PGN or Poly I:C) relative to PBS-treated
controls within each growth response group and tissue
are shown in Fig. 4a and Table 2. A total of 391 DEGs
were detected, with more DEGs (311) in head kidney
than in liver (213 DEGs), and more DEGs for PGN (358)
than Poly I:C (166). TR (316 DEGs) and W (152 DEGs)
displayed many more immune responsive genes than TF
(38 DEGs) and D (18 DEGs). A total of 57 genes showed
responses in multiple treatments and tissues (Additional
file 1: Table S1).
In head kidney and liver sampled after PGN treatment,
TR showed the most DEGs (71/123), followed by W (36/
116), TF (6/32) and D (3/14) (Table 2). The majority of
genes were up-regulated in response to PGN, but there
Table 1 Differentially expressed genes (DEGs) among PBS injected TF, TR, and D groups relative to W. DEGs with a fold change ≥3
are shown in bold (significant by Baggerley’s test, normalized FDR correction P-value < 0.01)
Tissue Gene Annotation Fold change
TR/W TF/W D/W
Head kidney unigene22417332 Aquaporin 1 −1.5 1.1 −3.5
unigene22417191 ATP-dependent RNA helicase DHX30-like 6.4 3.1 1.7
unigene22417189 ATP-dependent RNA helicase DHX30-like 4.9 2.6 1.6
unigene22386458 B chain crystal structure of avidin 2.8 4.1 −2.0
unigene22392248 Complement C1q-like protein 4 precursor −3.6 −1.9 −2.0
unigene22390619 Leucine-rich repeat-containing protein 19 4.6 3.0 1.7
unigene22396071 Methyltransferase DDB-like 6.2 4.1 3.1
unigene22408729 Perforin-1-like isoform X1 −1.5 −1.1 −3.7
unigene22418289 Sodium channel protein type 4 subunit alpha B 53.9 11.9 −2.4
unigene22385893 Uncharacterized protein LOC109903204 −2.2 −1.4 −5.2
unigene22389921 Uncharacterized protein LOC109904151 −1.5 −1.0 −3.6
unigene22393685 Uromodulin −1.3 1.1 −3.6
unigene22425942 ORF2 protein 3.8 1.2 1.2
Liver unigene22426268 Fatty acid-binding protein 1 −1.1 −4.0 −2.7
unigene22387365 Microfibril-associated glycoprotein 4-like −3.2 −1.5 1.3
unigene22426266 Saxitoxin and tetrodotoxin-binding protein 1 −3.5 −1.5 1.3
unigene22418289 Sodium channel protein type 4 subunit alpha B 30.2 8.9 −1.0
unigene22391480 Transmembrane protein 116 −8.9 −2.3 1.0
unigene22426238 C-C motif chemokine 19-like −4.3 3.0 1.8
PBS phosphate-buffered saline, PGN peptidoglycan, Poly I:C polyinosinic-polycytidylic acid. W, non-transgenic (wild-type) coho salmon on a full satiation ration, TF
GH transgenic coho salmon on a full satiation ration, TR GH transgenic coho salmon on restricted ration equal to that consumed by W, D domesticated coho
salmon on a full satiation ration
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was extensive variation in responses among the different
groups (Additional file 1: Table S1). Indeed, only one
gene (cathelicidin antimicrobial peptide precursor) was
commonly up-regulated in all fish groups in response to
either immune mimic and either tissue (liver, PGN treat-
ment; Additional file 1: Table S1). The gene encoding
epidermis-type lipoxygenase 3 downregulated by PGN in
head kidney in three growth response groups (TR, TF,
and W, while three genes (encoding diacylglycerol O-
acyltransferase 2 gene, regulator of microtubule dynam-
ics protein 2 gene, and the diablo mitochondrial gene)
showed downregulation in response to PGN in liver in
TR, TF, and W (Additional file 1: Table S1).
For Poly I:C treated groups, few DEGs were detected
in D (0 in head kidney and 1 in liver) and none in either
tissue for TF. In contrast, TR showed many up-regulated
genes (97 in head kidney and 25 in liver) and W had 7
in head kidney and 36 in liver). No downregulated DEGs
were detected (Table 2 and Additional file 1: Table S1).
These data reveal a strong difference in response to
Poly I:C between faster growing genotypes (TF and D)
vs. slower growing groups (W and TR). Overall, the two
strains with accelerated growth (TF and D, relative to
W) each showed a reduced transcriptomic response to
both immune mimics in liver and head kidney.
Conversely, TR showed evidence for an augmented
transcriptomic response to both immune mimics in liver
and head kidney compared to W.
Cluster analysis showed that, among all DEGs, D and
TF were grouped most closely for all tissues and treat-
ments with the exception of head kidney treated with
PGN where W and TF were clustered closely in the head
kidney treated with PGN (Fig. 4b).
Immunological pathway analysis using KEGG analysis
Within the coho salmon transcriptome [22], KEGG ana-
lysis revealed that approximately 24,772 consensus se-
quences were significantly associated with KEGG ID
codes. Among those, 12,294 sequences were matched to
7223 KEGG IDs for known metabolic or signalling path-
ways. Among those, 753 sequences were classified as
immune-related amongst 16 immune pathways (data not
shown). For comparisons between immune stimulated
and PBS-treated fish within each group, 193 sequences
were found as immune-related DEGs (Table 3). Among
these 193 DEGs, 21 immune-related DEGs (9 in head
kidney, 15 in liver, 3 in common) were found from PGN
treatment (Table 3). For Poly I:C treatment, 15 DEGs
(11 in head kidney, 8 in liver, 4 in common) were found
as immune-related genes (Table 3). In cluster analyses,
W and TF were closely related in the PGN treatment
Fig. 3 Heatmap of differentially expressed genes (DEGs) from comparisons among PBS-treated groups a) head kidney and b) liver. A star within
cells refers to DEGs determined by the criteria of fold-change ≥3, and a normalized false discovery rate (FDR) P-value correction < 0.01. See Fig. 1
legend for abbreviations
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Fig. 4 a) Number of differentially expressed gene (DEG) shared among comparisons within the fish groups (TF, TR, W, D) treated with immune
stimulants Poly I:C, relative to each respective fish group treated with PBS, for both head kidney and liver. b) Heatmap for all significant
differentially expressed gene (DEG) for comparison within fish groups treated with immune stimulants compared the same group treated
with PBS for both head kidney and liver. Hierarchical clustering analysis was performed by MeV (ver. 4.9; https://sourceforge.net/projects/
mev-tm4/files/mev-tm4/). A star within cells refers to DEGs determined by the criteria of fold-change ≥3, and a normalized false discovery
rate (FDR) P-value correction < 0.01. See Fig. 1 legend for abbreviations
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Table 2 Number of differentially expressed gene (DEG) determined from comparison of treated groups relative to their respective
PBS-treated group. Treatments were the bacterial mimic peptidoglycan (PGN) and viral mimic Poly I:C. An arrow refers to up or
down expression of DEG. A value in parenthesis is an average value of DEGs
Tissue Comparison D TR TF W
Head kidney PGN-treated vs. PBS-treated 3 ↑ 3 (6.6) 71 ↑ 64 (11.0) 6 ↑ 5 (17.3) 29 ↑ 28 (9.7)
– ↓ 7 (−3.8) ↓ 1 (−5.9) ↓ 1 (−5.5)
Poly I:C-treated vs. PBS-treated 0 – 97 ↑ 97 (6.6) 0 – 7 ↑ 7 (7.1)
– – – –
Liver PGN-treated vs. PBS-treated 14 ↑ 14 (18.6) 123 ↑ 109 (11.0) 32 ↑ 27 (14.4) 80 ↑ 72 (9.8)
– ↓ 14 (−6.7) ↓ 5 (−4.8) ↓ 8 (−11.8)
Poly I:C-treated vs. PBS-treated 1 ↑ 1 (7.3) 25 ↑ 24 (9.8) 0 – 36 ↑ 36 (7.6)
– ↓ 1 (−3.8) – –
PBS phosphate-buffered saline, PGN peptidoglycan, Poly I:C polyinosinic-polycytidylic acid. W, non-transgenic (wild-type) coho salmon on a full satiation ration, TF
GH transgenic coho salmon on a full satiation ration, TR GH transgenic coho salmon on restricted ration equal to that consumed by W, D domesticated coho
salmon on a full satiation ration
Table 3 Number of differentially expressed gene (DEG) associated with immune-related KEGG pathways determined in both head
kidney and liver for peptidoglycan (PGN) and poly I:C treated fish, assessed by comparison of against PBS-treated fish in each same
group. Total number of DEGs of each genotype were different from the sum of values because some genes have multi-functional
characteristics by KEGG pathway analysis
Immune-related KEGG pathway PGN-treated / PBS-treated Poly I:C-treated / PBS-treated
Full name Abbreviation Head kidney Liver TotalDEG Head kidney Liver Total DEG
D TR TF W D TR TF W D TR TF W D TR TF W
Antigen processing and presentation APP 2 2 2 2 1 3
Complement and coagulation
cascades
CCC 1 1 1 2 1 1
Cytosolic DNA-sensing pathway CDs 0 1 1
C-type lectin receptor signaling
pathway
CLRs 1 1 2 1 1 1
Chemokine signaling pathway Cs 2 1 2 3 1 1 4
Fc gamma R-mediated phagocytosis FGRP 2 1 1 1 3 0
Intestinal immune network for IgA
production
IINIP 0 1 1
IL-17 signaling pathway ILs 1 2 1 1 2 1 1 2
Leukocyte trans-endothelial migration LTM 2 1 1 3 1 3 0
NOD-like receptor signaling pathway NRs 1 1 3 1 2 1 4
Platelet activation PA 1 1 0
RIG-I-like receptor signaling pathway RRs 0 2 1 3 3
Th17 cell differentiation TCD 0 1 1 1 1 3
Toll and Imd signaling pathway TIs 1 1 2 2 0
Toll-like receptor signaling pathway TRs 2 2 2 2 1 2
Th1 and Th2 cell differentiation TTCD 0 1 1 1
Total 9 1 3 1 13 3 10 21 18 4 8 7 15
Average fold change 3.0 3.3 6.9 10.9 15.8 5.5 2.8 9.0 12.8 7.3 7.9 4.2 16.0
PBS phosphate-buffered saline, PGN peptidoglycan, Poly I:C polyinosinic-polycytidylic acid. W, non-transgenic (wild-type) coho salmon on a full satiation ration, TF
GH transgenic coho salmon on a full satiation ration, TR GH transgenic coho salmon on restricted ration equal to that consumed by W, D domesticated coho
salmon on a full satiation ration
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(Fig. 5a), whereas D and TF were clustered together for
the Poly I:C treatment (Fig. 5b).
Discussion
The present study has examined the transcriptomic re-
sponse to immune stimulation in four coho salmon
groups possessing different growth rates arising from
domestication, GH transgenesis and ration level.
Transcriptome-level alterations caused by treatment
with pathogen mimics were found to be very complex,
affecting multiple pathways to various degrees, similar
to results seen in other studies [23, 24]. Immune chal-
lenges with bacterial and viral mimics previously have
been used to explore tissue and time-dependent re-
sponses to identify tissue-specific immune processes in-
volved in different activation phases of an infection [25–
28]. Treatment conditions (viral vs. bacterial mimics)
and fish group (growth response group and environmen-
tal influences) were all found to affect the pathways in
distinct ways, including many responses that depended
on interacting factors.
Basal level gene expression differences
To determine whether the four fish growth response
groups (W, TF, TR, D) had any innate basal differences
in gene expression, we first compared PBS-treated
Fig. 5 Heatmap for immune-related KEGG pathway-annotated differentially expressed gene (DEG) for both a) head kidney and b) liver for each
comparison within the fish groups treated with PGN and Poly I:C. Hierarchical clustering analysis was performed by MeV (ver. 4.9; https://
sourceforge.net/projects/mev-tm4/files/mev-tm4/). A star within cells refers to DEGs determined by the criteria of fold-change ≥3, and a
normalized false discovery rate (FDR) P-value correction < 0.01. See Fig. 1 legend for abbreviations
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groups lacking immune stimulant treatment. Among 18
DEGs identified, perforin-1-like isoform X1 in head kid-
ney and C-C motif chemokine 19-like gene in liver were
identified as immune-related genes. Perforin-1, which is
involved in natural killer cell mediated cytotoxicity, was
significantly down-regulated in expression in D only (−
3.7-fold change relative to W). In mammals, perforin
plays a central role in secretory granule-dependent cell
death induced by natural killer T cells and cytotoxic T
lymphocytes, important for defence against virus-
infected or neoplastic cells [29, 30]. Perforin also has a
structural similarity with the ninth component of com-
plement (C9) [31], and plays an important role in killing
cells that are recognized as non-self by the immune sys-
tem [32]. For fish perforin genes, limited studies have
been reported. In zebrafish, 6 perforin genes were char-
acterized [33] with potential for multiple functions. In
Olive flounder (Paralichthys olivaceus), a significant
increase of perforin expression in head kidney was ob-
served in the early developmental stage, suggesting that
perforin may play a key role in the innate larval immune
system [34]. Flounder and carp (Cyprinus carpio) show
specific cell mediated cytotoxicity using mainly a per-
forin/granzyme-like pathway [35, 36]. The head kidney
is an important organ with key regulatory functions and
is a central organ for immune-endocrine interactions
and neuroimmunoendocrine connections [37, 38]. It is
unclear whether down-regulation of the perforin-1 like
gene in D fish observed in the present study leads to an
attenuated innate immune response. However, that per-
forins play a crucial role in immune signalling pathways
suggests that further functional studies on this gene
would be of value to elucidate the molecular regulatory
mechanisms of its action in response to strains with
different growth rates that may cause trade-offs with im-
mune function. The differential response of strains ex-
amined here with respect to perforin expression suggests
that mechanisms affecting immune function arise by
separate mechanisms, at least in part, during transgen-
esis, domestication, and ration restriction.
The C-C motif chemokine 19-like gene in liver showed
a significant decrease in expression in TR fish compared
to other groups. This gene plays a role in the chemokine
signalling pathway, but has only been studied in a few
fish species such as turbot (Scophthalmus maximus),
striped murrel (Channa striatus), channel catfish
(Ictalurus punctatus), and ayu (Plecoglossus altivelis)
[39–42]. In these studies, the C-C motif chemokine 19-
like mRNA expression was highly upregulated upon bac-
terial and viral infection, consistent with findings in the
present study using bacterial and viral mimics. Distinct
from the overall elevation of immune response seen in
TR, the significantly lower basal level expression of the
C-C motif chemokine 19-like gene in TR fish may arise
from nutritional insufficiency and energy imbalance that
prevents full development of this immunological re-
sponse by reducing the ability to mobilize immune cells
to a site of infection. While further investigation is re-
quired, this observation suggests that in some cases GH
overexpression in the absence of adequate nutritional in-
put may cause pathological response to immune stimu-
lation as is observed in other species and strains that
possess balanced energy status.
The high expression of the sodium channel protein
type 4 subunit alpha B gene in both tissues in TF and
TR groups is intriguing. In general, sodium channel pro-
tein type 4 subunit alpha protein is expressed in skeletal
muscle, neurons, and other tissues, and is known to play
a role in the generation and propagation of action poten-
tials in neurons and in muscle in animals. It provides a
critical function, and mutation of this gene leads to sev-
eral myotonia and periodic paralysis disorders [43–45].
Previous research has found that GH over-expression
can have very broad pleiotropic effects on many path-
ways related to physiological, morphological, and behav-
ioural phenotypes of the organism [20, 25]. The strong
response of sodium channel protein type 4 subunit alpha
B gene to GH transgenesis may be another example of
pleiotropic responses, or this gene may be involved in
some yet unknown immune response process.
Metabolic and growth gene pathway differences
Differences in metabolic and growth gene pathways
among the groups prior to treatment were also exam-
ined to identify differences that may result in trade-offs
with immune function (i.e. growth vs. immunity) [7, 11,
46]. In the present study, two ATP-dependent RNA heli-
case DHX30-like genes in head kidney were identified to
have a molecular function related to metabolism. RNA
helicases generally act as components of multi-protein
complex with additional ATP-independent roles pre-
sumably conferred through their interactions with pro-
tein partners [47], while also playing an important role
in the assembly of the mitochondrial large ribosomal
subunit [48]. In the present study, significantly higher
expression of two ATP-dependent RNA helicase
DHX30-like genes was seen in TF and TR vs. W when
compared to D vs. W, suggesting the high level of GH
produced in both GH transgenic salmon groups [17]
may be influencing this pathway. In human cells,
overexpression of ATP-dependent RNA helicase
DHX30-like gene causes high production of viral Gag
proteins and elevates the production of virus particles,
leading to enhanced human immunodeficiency virus
type 1 transcription [49]. It is not clear if overexpression
of basal ATP-dependent RNA helicase DHX30-like
mRNA would affect T (GH transgenic) salmon
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immunodeficiency, but further studies on this gene
would be of value to assess trade-offs in a range of envir-
onmental conditions.
Previous studies comparing GH transgenic and non-
transgenic fish have found significant effects on lipid
metabolism pathways [11, 46, 50, 51]. In the present
study, fatty-acid binding protein 1 was significantly
down-regulated in TF liver compared to other groups.
Fatty-acids affect many aspects of cellular function as an
energy source and as signals for metabolic regulation,
modulation of gene expression, growth and survival
pathways, and inflammatory and metabolic responses
[52, 53]. The fatty-acid binding protein 1 is known as a
liver-fatty-acid binding protein, and its mRNA level is
increased by fatty acids, dicarboxylic acids and retinoic
acid. Effects relating to fatty-acid metabolism have also
been reported in other GH transgenic salmonids using
the OnMTGH1 transgene [13]. For both amago salmon
(Oncorhynchus masou) and Arctic charr (Salvelinus alpi-
nus L.), reduced D6-desaturase has been observed, an
enzyme involved the innate immune systems [54, 55].
These data may be species-specific as reduced expres-
sion of D6-desaturase was not seen in present study.
Using microarray analysis, enhanced expression of genes
in hepatic tissues have also been seen in GH transgenic
amago salmon, specifically NADH dehydrogenase,
leucite-derived chemotaxin2, and complement factor H
[54]. These genes were stimulated in TF in liver in the
present study (data not shown, > 2-fold change). In case
of lectin, this gene showed strongly reduced expression
in GH transgenic amago salmon [54], but increased ex-
pression in TF coho salmon in the present study, again
indicating species-specific responses. In a previous study
with salmon (Salmo salar), lectin was strongly up-
regulated during infection [56], corresponding with a
previous result with GH transgenic coho salmon [19]
and with the present study.
Immune response differences upon immunological
stimulation
Previous studies examining domesticated and transgenic
coho salmon using microarray technology have found
that gene expression profiles, relative to wild type, were
highly correlated and revealed changes in multiple pro-
cesses including e.g. energy metabolism of carbohydrates
and lipids, cellular structure, and immune function [11,
57]. Domesticated salmon have been shown to have ele-
vated GH and IGF-I (insulin-like growth factor) levels
relative to wild type [7, 10, 11], albeit not as high as seen
in GH transgenic animals [17]. Thus, many changes in
these strains have been found to affect pathways simi-
larly. Consistent with previous microarray studies, cor-
relation analysis indicated that the overall pattern of
gene expression in GH transgenesis and domestication,
relative to wild strain, were affected to a significant ex-
tent in parallel ways. Interestingly, the fully-fed trans-
genic group (TF) showed higher correlations with the
domesticated strain (D) than did ration-restricted trans-
genic salmon group (TR), indicating that nutritional sta-
tus also may significantly affect homeostasis of energy
balance and gene regulation in transgenic salmon. Fur-
ther, although both D and TF strains both possess
enhanced growth relative to wild type, some differences
were observed between the strains suggesting that effects
on immune pathways can be strain-specific. This would
be expected because domestication arises from the grad-
ual selection of variation within a strain over multiple
generation with the opportunity for co-selection of other
traits that can compensate for negative pleiotropic ef-
fects. In contrast, GH transgenesis is a powerful and im-
mediate influence on the physiology of an animal whose
genome has evolved for lower growth rates, and thus
such animals are likely to experience more pleiotropic
effects and have limited capacity to compensate for
negative epistatic interactions caused by suddenly modi-
fied growth and metabolic pathways.
In several previous studies, TR coho salmon have
shown uncoupling of GH and amino acid metabolism
signals caused by long-term nutritional insufficiency
affecting expression of genes associated with multiple
pathways [18, 58–60]. These additional costs and trade-
offs have the potential to cause TF and TR salmon to
encounter critical energy imbalance which in turn could
reduce energetic support of essential immunological
mechanisms needed to cope with infection.
An overall similar response of immune-relevant genes
between T and D has been observed, but pathway-
specific differences were also found (e.g. chemokine sig-
nalling pathway), suggesting the presence of non-parallel
responses to immune stimulation among strains (Fig. 6).
TF has fewer immune responses than TR and D, and in
particular, there were no significant immune-related
DEGs in TF in liver for both pathogen mimics, indicat-
ing disease resistance of these animals in culture is likely
reduced (at least relative to W [19]) and they may be less
able to respond to pathogen exposure. A greater number
of immune-relevant genes were up-regulated in TR than
in TF, suggesting that TR may have enhanced capacity
to respond to infection to a greater extent than seen for
TF. TF salmon possess an elevated basal metabolic rate
[61] relative to wild salmon and unsatiated T salmon,
and this overall enhancement of metabolism may affect
energy available for immune responses. TF salmon have
been shown to have reduced disease resistance [19, 20]
and it is possible this arises from hyper-fast growth pre-
venting development of a full immune response, whereas
in TR animals where growth is maintained at a lower
wild-type rate by ration restriction, a higher immune
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response may be physiologically possible. Indeed, it is
well-known that a rapid growth rate and immunity
showed an inverse relation in aquaculture [62–64]. Pre-
vious studies examining immune and growth-related
gene expression in muscle of W, TF, TR and D groups
treated with Poly I:C or PGN found complex responses
depending on the pathways examined [21]. Strikingly,
PGN treatment induced a strong pro-inflammatory re-
sponse [e.g. TNF-α (tumor necrosis factor-alpha) among
others] in all groups but TF, and that TF salmon had
higher basal levels of expression suggesting this latter
strain may be experiencing a chronic inflammatory re-
sponse and possesses little ability for further stimulation.
Poly I:C treatment was found to induce viral-response
genes in all groups but TF, again suggesting a dampened
response in this fast-growing salmon group as seen in
the present RNA-Seq study in head kidney and liver.
This study also noted that PGN and Poly I:C modified
the expression GH axis genes which, coupled with the
effects of GH overexpression seen in the present study,
suggests significant cross-talk exists between growth and
the immune system. Consistent with this conclusion, en-
hancement of energy-sensing AMPK (AMP-activated
protein kinase) subunits has been observed in fast grow-
ing transgenic salmon [65], and immune stimulation was
seen to reduce expression of several AMPK subunit-
encoding genes specifically in GH-transgenic fish, con-
firming the interaction between growth and immune
pathways.
The data in the present work extend previous findings
that showed the innate immune system of this GH
transgenic strain (TF) was less effective (in response to
Aeromonas salmonicida treatment), whereas the ac-
quired immune response could provide full immunity
Fig. 6 Diagram illustrating relationships of significant immune-related KEGG pathway differentially expressed gene (DEG) identified within the fish
groups treated with a) bacterial and b) viral mimics. The number and size of circles within the figure corresponds to the number of DEG in the
affected pathway. Overlapping circles represent shared responses. The color of each circle refers to the value of gene expression according to the
fold change. See Fig. 1 legend for abbreviations
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[20]. Further, higher susceptibility of GH transgenic
coho salmon to a bacterial (Vibrio anguillarum) chal-
lenge has been observed relative to that seen in wild-
type [19]. In GH transgenic carp, elevated lysozyme and
serum bactericidal activity have been observed, suggest-
ing that disease resistance may be enhanced [66],
whereas treatment with GH protein has shown complex
modulations of immune responses in several fish species
[67–71]. Together, species- and strain-specific immuno-
logical responses have been detected in fishes exposed to
elevated GH.
Analyses of immune-related DEGs within groups of
coho salmon demonstrating different growth responses
found that most pathways were up-regulated in response
to bacterial and viral mimic stimulations with the excep-
tions of c-type lectin receptor signalling (CLRs) and
chemokine signalling pathways (Fig. 6). In particular, the
CLRs from bacterial stimulation responded only in
transgenic fish groups (TF and TR), suggesting that the
CLRs pathway would be a valuable direction for further
research to understand how GH influences shaping the
immune response to pathogens in growth modified ani-
mals. The effects in NOD-like receptor signalling
pathway (NRs) in W, platelet activation in TR, and no
immune responses in TF, show group specific responses
to immune simulants, and as such these responses pro-
vide avenues to begin to further dissect differences be-
tween GH transgenic and domesticated strains.
Conclusion
This study has examined trade-offs between growth rate
and immune function arising from anthropogenic en-
hancement of growth rates by selective breeding and
genetic engineering (GH transgenesis) and has found
significant interaction between these two critical path-
ways. The findings are multi-faceted and improve our
understanding of the pleiotropic effects of growth modi-
fication on the immunological responses in fish, reveal-
ing that different genetic modification approaches and
rearing conditions (i.e. nutritional state) influence gene
expression profiles and pathways in unique complex
ways (Fig. 6). The study also identified a strong positive
response to ration restriction on immune function in the
GH transgenic salmon group which warrants further
study in other growth accelerated strains. These data will
assist with development of strains and culture conditions
for aquaculture by allowing development of genetic
markers that reveal effects on immune function in re-
sponse to programs seeking to enhance growth rate. In
addition, the information identified in this study improve
our understanding of effects of growth on immune func-
tion and thereby fitness to aid in ecological risk assess-
ments of modified strains (transgenic, domesticated, or
other) that have the potential to introgress into natural
populations.
Methods
Experimental set up
Experiments were performed at Fisheries and Oceans
Canada (Department of Fisheries and Oceans; DFO) in
West Vancouver, Canada. This facility is designed with
containment measures to prevent the escape of
genetically-modified fish to the natural environment. All
experiments were performed in compliance with the
Canadian Council on Animal Care guidelines under a
permit from DFO’s Pacific Regional Animal Committee
(Animal Use Permit 12–017). Four size-matched popula-
tions of juvenile coho salmon, Oncorhynchus kisutch,
were generated: (i) 19-month-old wild-type coho salmon
fed to satiation (W), (ii) 10-month-old non-transgenic
domesticated coho salmon selected for rapid growth and
fed to satiation (D), (iii) 6-month-old GH transgenic
coho salmon fed to satiation throughout life and posses-
sing elevated growth rate relative to W (TF) [72], and
(iv) 17-month-old GH transgenic salmon that were
ration-restricted to the W satiety level, leading to wild-
type growth rate throughout life (TR). TR fish were pro-
duced by pair feeding them (at each feeding session) the
same amount of food that had immediately prior been
consumed by the W group that had been fed to sati-
ation. Satiation was defined as the condition when three
singly offered food pellets reached the bottom of the
tank without consumption. Under these conditions, and
because of the vigorous appetite of transgenic fish, this
resulted in consumption of the same amount of food by
the W and TR groups. Using fish of different ages was
necessary to standardize confounding effects of body size
on gene expression, due to the highly different growth
rates among groups. All groups of fish, n = 500 individ-
uals (125 fish per each group) were maintained under
the same standard conditions (4000 L tanks supplied
with 10.5 ± 1 °C aerated well water, natural photoperiod,
fish density less than 5 kg/m3) and were fed commercial
salmonid diets (Skretting Canada Ltd.) twice daily at 9:
00 a.m. and 15:00 p.m. For each size matched group, n =
60 individuals (W: 74.2 ± 3.6 g, D: 77.9 ± 0.5 g, TF: 77.9 ±
6.1 g, TR: 78.6 ± 3.3 g) were distributed into four separate
70 L tanks. Within each tank, three experimental groups
were uniquely marked and then intraperitoneally
injected with the following treatments: i) n = 24 per tank
with polyinosinic-polycytidylic acid (Poly I:C) at 200 μg
per 100 g fish weight, ii) n = 24 per tank with peptidogly-
can (PGN) at 200 μg per 100 g fish weight and iii) n = 24
per tank with phosphate-buffered saline (PBS) as a con-
trol. After treatment, all fish were re-stocked back into
4000 L tanks and maintained under the common garden
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design described above. The concentrations of Poly I:C
and PGN used were based on past work [73–77].
Sampling and RNA extraction
For each growth response group (TF, TR, W, and D), 10
fish were sampled 6 h and 30 h post-treatment. Individ-
ual fish were rapidly euthanized with a lethal concentra-
tion of tricaine methanesulfonate (200 mg/L; Syndel
Laboratories Ltd., Vancouver, BC, Canada; buffered in
400 mg/L sodium bicarbonate) after initial sedation
using Aquacalm (1mg/L; Syndel Laboratories Ltd., Van-
couver, BC, Canada). A range of different tissues, includ-
ing head-kidney, intestine, liver, skeletal muscle, and
spleen, were rapidly team dissected (< 3 min per fish)
and stored in RNAlater™ (ThermoFisher Scientific) over-
night at 4 °C, followed by long-term storage at − 20 °C.
For this study, total RNA was extracted from head
kidney and liver samples at the 30 h time point using
RNeasy mini kits (Qiagen, Valencia, CA, USA). Concen-
tration and purity of the RNA for each sample was
measured using a Nanodrop (Thermo Scientific,
Wilmington, DE, USA), and RNA integrity confirmed
using an Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Palo Alto, CA, USA). Five individual RNA samples
were randomly selected from each group per treatment
for RNA-Seq analysis.
RNA-Seq analysis
High-quality RNA (RNA integrity number > 9.0) prepa-
rations were quantified using an Invitrogen Qubit
Fluorometer and Agilent 2100 Bioanalyzer. The sequen-
cing libraries were made from 2 μg of pooled RNA
(0.4 μg per fish from each of 5 fish per pool), creating
two biological replicates per growth response group (i.e.
n = 2 pools, each of n = 5 fish per treatment. Libraries
(200 bp short-insert) were made with the TruSeq™ RNA
sample preparation kit (Illumina, San Diego, CA, USA).
Sequencing was conducted using the Illumina
HiSeq2000 platform to generate 50-bp single-end reads
by the Beijing Genomics Institute (BGI, Shenzhen,
China). A total of 617,779,232 reads were generated.
After removal of adaptor sequences, ambiguous nucleo-
tides (N ≥ 10%), low-quality reads (where > 50% of bases
had quality value scores ≤5) and sequences less than 15
bp, ~ 561 million reads (head kidney: 276,802,892, liver:
284,410,895) totalling 27.5 billion bases were obtained
using the filter_fq software (BGI internal software) for
further analysis.
For differential expression (DE) analysis, two different
pipelines were used in this study. First, the RobiNA
pipeline [78] was used, including for quality checks using
default parameters. Within RobiNA, Bowtie 2 [79] was
used for read mapping (mismatch cost = 2) against a ref-
erence coho salmon transcriptome [22]. Subsequently,
DE analysis was performed in DESeq2, which assumes a
negative binominal distribution of count data [80].
Second, CLC Genomics Workbench (Ver. 8.0.2) was
used following a previous approach [81]; here, imported
clean reads were mapped against the reference transcrip-
tome, the insert size for paired-end reads was set be-
tween 150 and 250 bp and RPKM normalization of
expression values was performed [81]. Identification of
DE genes (DEGs) using the CLC approach was based on
the RPKM values analysed using Baggerley’s test [82].
For both the DESeq2 and CLC approach, DEGs were fil-
tered using a false-discovery correction rate (P < 0.01)
and fold change cut-off ≥3. Pairwise comparisons made
within growth response groups are shown in Fig. 2a.
Principal component analysis was performed using CLC
Genomics Workbench (Ver. 8.0.2). We note that the
methods used here for normalization of RNA-Seq data
present expression relative to the pool of sequenced
transcripts in a given sample rather than as an absolute
measure of gene expression per cell. DEGs were identi-
fied after comparing expression in treatment groups to
normalized expression seen in wild type, and as such
provide a relative measure of gene expression among
treatment groups. We note that raw read numbers ob-
tained for RNA-Seq were highly similar among groups
(Additional file 2: Table S2).
For the following described analysis, commonly de-
tected DEGs identified by both normalization methods
were used. We chose to analyze only those genes found
significant by both methods to focus our analysis on the
most analytically robust DEGs. Using Blast2GO v3.1
[83], DEGs were assigned gene ontology (GO) terms for
‘biological process’, ‘cellular component’ and ‘molecular
function’. The KAAS, Kyoto Encyclopedia of Genes and
Genomes (KEGG) automatic annotation server [84, 85]
was used for pathway analysis, focused on signalling and
hormone pathways related to the immune response.
Real-time quantitative PCR validation of RNA-Seq data
The same samples used in RNA-Seq (n = 2 pools of 5
fish per growth response group/treatment) were sub-
jected to qPCR validation for a subset of DEGs. First-
strand cDNA was synthesized from total RNA (0.5 μg)
using the High Capacity cDNA synthesis kit with RNase
inhibitor (Applied Biosystem, Foster City, CA, USA).
Primers for qPCR (Additional file 3: Table S3) were de-
signed with sequences from the coho salmon transcrip-
tome [84] and checked for secondary structures using
NetPrimer (http://www.premierbiosoft.com). All pairs of
primers were validated for specificity by electrophoresis
to confirm the expected amplicon size. Quantitative
PCR (qPCR) was performed using 10 μl of Fast SYBR
Green Master Mix (Invitrogen) with 0.2 μM/l of each
primer, 5 μl of 20-fold diluted cDNA and nuclease-free
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water (Gibco, Carlsbad, CA) to a final volume of 20 μl in
96-well plates (Applied Biosystem, Forster City, CA).
The reaction was performed in triplicate using the 75
Fast Real time PCR System (Applied Biosystem) with the
reaction conditions: 95 °C/10 min; 40–45 cycles of 95 °C/
2 s, 60 °C/15 s, 72 °C/33 s. After qPCR, a melt curve ana-
lysis was performed to verify the presence of a single
amplicon peak. Levels of mRNA were calculated relative
to the Ct value obtained for the reference gene (Ubiqui-
tin) using the 2-ΔΔCt method [86]. Ubiquitin was chosen
for normalization as it possessed the most stable mRNA
levels for the growth response and treatment groups
among three potential reference genes examined [β-
actin, Ef-1a and Ubiquitin (Additional file 3: Table S3)].
This normalization procedure accounts for differences in
the proportion of mRNA relative to total RNA in a cell
among groups.
qPCR validation
qPCR analysis was performed for 8 early response and
immune-associated genes (encoding Mx2 protein, Serum
amyloid A-5 protein, Interleukin-8, Hepcidin, Radical S-
adenosyl methionine domain-containing protein 2 pre-
cursor, Immune-responsive gene 1 protein homolog,
TNF receptor superfamily member 5A, and MHC class I
alpha chain) in order to supplement and validate RNA-
Seq analysis (Additional file 4: Figure S1).
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